IBI318 Plus Lenvatinib Tackles Resistant Lung Cancer
In a groundbreaking development in the realm of cancer immunotherapy, a recent Phase II clinical trial has unveiled promising results ...
In a groundbreaking development in the realm of cancer immunotherapy, a recent Phase II clinical trial has unveiled promising results ...
A groundbreaking phase II clinical trial has unveiled promising results in the fight against advanced hepatocellular carcinoma (HCC) by combining ...
In a groundbreaking advancement for the treatment of non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations, ...
In a groundbreaking advancement in oncology, researchers at the Abramson Cancer Center of the University of Pennsylvania have unveiled results ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine